Weina Sun

Title: Weina Sun: Innovator in Influenza Research

Introduction

Weina Sun is a prominent inventor based in New York, NY (US), known for her significant contributions to the field of influenza research. She has developed innovative solutions aimed at improving immunization against influenza viruses. Her work is particularly focused on the engineering of hemagglutinin polypeptides, which play a crucial role in the virus's ability to infect host cells.

Latest Patents

Weina Sun holds a patent titled "Mosaic influenza virus hemagglutinin polypeptides and uses thereof." This patent describes a mosaic influenza virus hemagglutinin (HA) polypeptide that includes an influenza A virus HA ectodomain. The HA ectodomain consists of an HA stem domain and an HA globular head domain, with the latter engineered to include amino acid substitutions in various antigenic sites. The patent also covers immunogenic compositions that utilize this mosaic influenza virus HA polypeptide, as well as methods for immunizing subjects against influenza A virus by administering these compositions.

Career Highlights

Weina Sun is affiliated with the Icahn School of Medicine at Mount Sinai, where she conducts her research. Her work has garnered attention for its potential to enhance vaccine efficacy and provide better protection against influenza viruses. With her innovative approach, she is making strides in the field of virology and immunology.

Collaborations

Weina collaborates with esteemed colleagues such as Adolfo Garcia-Sastre and Peter Palese, who are also recognized for their contributions to influenza research. Their combined expertise fosters a collaborative environment that drives forward the understanding and treatment of influenza.

Conclusion

Weina Sun is a trailblazer in the field of influenza research, with her innovative patent and collaborative efforts paving the way for advancements in immunization strategies. Her work exemplifies the importance of innovation in addressing public health challenges.